ADALTA LIMITED - Discussion

0.00%

0.3¢

Market Cap $8.927M

Healthcare Biotechnology

AdAlta Limited is an Australia-based drug discovery and development company. The Company... AdAlta Limited is an Australia-based drug discovery and development company. The Company is focused on using its technology platform to generate protein therapeutics, known as i-bodies, for treating a range of human diseases. The Company's principal activity is to develop its ibody platform with a focus on its lead candidate AD-114, a treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases. Its i-body AD-114 drug candidate is used for treatment in various fibrosis related eye diseases to support the pre-clinical development of the eye fibrosis indication. The Company's AD-114 has shown both anti-fibrotic and anti-inflammatory effects in various animal models. The Company's AD-114 is used in various therapeutic applications for fibrosis diseases of the liver, skin, kidney and heart. AD-114 has completed pre-clinical studies in vitro (in the lab) and in vivo (in animals) data obtained.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Adalta Limited

New Thread

REFRESH

First

Post Thread

Forum	Tag	Subject	View	Poster

REFRESH

First

Post Thread

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $8.927M

Open	High	Low	Volume
0.3¢	0.3¢	0.3¢	263K

Buyers (Bids)

Vol.	Price($)
22402218	0.3¢

Sellers (Offers)

Price($)	Vol.
0.4¢	14374438

Last trade - 07.00am 31/07/2026 (20 minute delay)

1AD (ASX) Chart